600673 Guangdong Hec Technology Holding
- 8.37
- -0.18-2.11%
Guangdong Hec Technology Holding News
Express News | ST Sunshine: Controlling shareholder Sunshine Group has frozen a total of 172.7 million shares
Sunshine Group, the controlling shareholder of Sunshine Dairy (001318.SZ), increased its holdings by 1,685,400 shares
Sunshine Dairy (001318.SZ) issued an announcement. The controlling shareholder, Sunshine Group, will be held from February 6, 2024 to 202...
Dongyangguang (600673) covered for the first time: leading domestic enterprises in electronic components, high-end aluminum foil and energy materials
The company is a leading domestic enterprise in electronic components, high-end aluminum foil and energy materials. The company's main business includes four major sectors: electronic components, high-end aluminum foil, new chemical materials, and energy materials. The company's core products include electrode foil for aluminum electrolytic capacitors (package
Express News | Dongyang and others invested 600 million yuan to establish a corporate management partnership
Dongyangguang Industrial: The company changed the audit agency
Shenzhen Dongyangguang Industrial Development Co., Ltd. announced that the company changed the financial reporting auditing agency from Tianjian Certified Public Accountants (Special General Partnership) Sichuan Branch to China Audit Asia Pacific Accounting Firm (Special General Partnership).
Dongyangguang Changjiang Pharmaceutical (01558.HK) plans to pay a special dividend of HK$1.5 per share
Dongyangguang Changjiang Pharmaceutical (01558.HK) announced that it intends to pay a special dividend of HK$1.5 per share.
Guangdong Dongyangguang Pharmaceutical plans to absorb and merge Dongyangguang Changjiang Pharmaceutical (01558) to resume trading on May 13
Dongyangguang Changjiang Pharmaceutical (01558) announced that the company's shares will be at 9:00 a.m. on May 13, 2024...
Dongyangguang Changjiang Pharmaceutical (01558.HK) was absorbed by Guangdong Dongyangyang Pharmaceutical at a premium of about 71.71% and resumed trading on the 13th
Gelonghui, May 10, 丨 Dongyangguang Changjiang Pharmaceutical (01558.HK) announced that on May 10, 2024, the offender Guangdong Dongyangyang Pharmaceutical Co., Ltd. has entered into a merger agreement with the company. According to this, the offeror and the company have agreed to implement the merger in accordance with the terms and conditions of the merger agreement. After the prerequisites and such conditions are met and the share exchange is completed, the company will be delisted. The offeror's H shares will be listed on the main board of the Stock Exchange by means of an introduction, and the company will be merged and absorbed by the offeror in accordance with the terms of the merger agreement, Chinese company law and other applicable Chinese laws. Shareholders in exchange will be entitled to receive from the offeror:
Express News | ST Sunshine: The controlling shareholder received the “Advance Notice of Administrative Penalties” from the China Securities Regulatory Commission
Dongyangguang Changjiang Pharmaceutical (01558): Potential Offerers Are Still Exploring Possible Merger Plans
Dongyangguang Changjiang Pharmaceutical (01558) and potential offender Guangdong Dongyangguang Pharmaceutical Co., Ltd. jointly announced that it is likely to...
Dongyangguang Changjiang Pharmaceutical (01558.HK): Proposed election of the fourth board of directors and supervisors of the Supervisory Board
Dongyangguang Changjiang Pharmaceutical (01558.HK) issued an announcement that the term of the third board of directors is about to expire. On May 6, 2024, the company held a board meeting to consider and approve the following candidates for directors of the fourth board of directors of the company. It can only be confirmed after approval by the company's shareholders at the upcoming 2023 annual general meeting of shareholders of the company:
Guoxin Securities: The supply and demand pattern is improving, and there is strong certainty that third-generation refrigerants will continue to recover
Starting in February 2024, all parts of the country have taken many measures to promote “trade-in” of automobiles and home appliances to stimulate consumption vitality. Air conditioning schedule data showed beautiful performance, automobile sales data, and refrigerants continued the upward trend.
Guangdong HEC Technology Holding Co., Ltd (SHSE:600673) Not Lagging Industry On Growth Or Pricing
When you see that almost half of the companies in the Metals and Mining industry in China have price-to-sales ratios (or "P/S") below 1.3x, Guangdong HEC Technology Holding Co., Ltd (SHSE:600673) look
Changes in Hong Kong stocks | Dongyangguang Changjiang Pharmaceutical (01558) is now up more than 3%, and the procurement price of insulin is more moderate. The company plans to win the bid for 5 products
Dongyangguang Changjiang Pharmaceutical (01558) is now up more than 3%. As of press release, it is up 3.15% to HK$12.46, with a turnover of HK$18.895 million.
Dongyangguang's net profit to mother increased by more than 50% in the first quarter, and the in-depth layout of the industrial chain drove the high-quality development of enterprises
“Investor Network” On the evening of April 23, Guangdong Dongyangguang Technology Holdings Co., Ltd. (“Dongyangguang”, 600673.SH) released the 2024 first quarter results report. The report shows that in the first quarter of 2024, Dongyangyang achieved operating income of 2.83 billion yuan, an increase of 5.31% over the previous year, and achieved net profit of 98.76 million yuan, an increase of 50.46% over the previous year. While achieving a double increase in profit, it achieved impressive results of a net profit increase of more than 50%. The performance is good, and Dongyangguang is also willing to pay generous dividends. On March 29th, when Dongyang released its 2023 annual report,
Guangdong Hec Technology's Q1 Profit Rises 50%
Guangdong Hec Technology's (SHA:600673) attributable profit rose 50% year over year to 98.8 million yuan, or 0.033 yuan per share, in the first quarter, according to a Wednesday filing with the Shangh
On April 23, the bid for the special insulin collection continued procurement was opened at the Shanghai Hongqiao Hotel. The reporter noticed at the scene that the highest price of Novo Nordisk's Dite Insulin Injection was reported at 10.7. The price of 8
On April 23, the bid for the special insulin collection continued procurement was opened at the Shanghai Hongqiao Hotel. The reporter noticed at the scene that the highest price of Novo Nordisk's Dite Insulin Injection was reported at 10.7. The price of 82.2 yuan/stick was higher than the highest valid bid price of 79.2 yuan/stick for this subsequent purchase. After only 1 minute, the lowest price in the market produced Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd.'s Mendong insulin injection at a price of 18.87 yuan/bottle. An investor from an insulin company told the reporter on the scene that in the last round of collection, the price of some products was reduced by more than 70%, the price drop was very low, and the competition was very fierce. This time, the collection company was able to reduce the price
Express News | Tonghua Dongbao Insulin won the bid for successive insulin purchases at the lowest price
Express News | At the insulin collection renewal site, Dongyang Yangshang's offer was leaked
Express News | “Second Arrow” creates credit risk mitigation certificates and supports the issuance of 330 million ultra-short financing notes
Analysis
Price Target
No Data
